Progressive Cross-Reactivity in IgE Responses: an Explanation for the Slow Development of Human Immunity to Schistosomiasis?

被引:36
|
作者
Fitzsimmons, Colin M. [1 ]
Jones, Frances M. [1 ]
de Moira, Angela Pinot [1 ]
Protasio, Anna V. [2 ]
Khalife, Jamal [3 ]
Dickinson, Harriet A. [1 ]
Tukahebwa, Edridah M. [4 ]
Dunne, David W. [1 ]
机构
[1] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
[2] Wellcome Trust Sanger Inst, Cambridge, England
[3] Inst Pasteur, CNRS, UMR 8204, Ctr Infect & Immun Lille,Inserm,U1019, F-59019 Lille, France
[4] Ugandan Minist Hlth, Vector Control Div, Kampala, Uganda
基金
英国惠康基金;
关键词
MANSONI ADULT WORMS; CONCOMITANT IMMUNITY; HUMAN RESISTANCE; IN-VIVO; REINFECTION; EXPOSURE; ANTIGENS; AGE; SUSCEPTIBILITY; ASSOCIATION;
D O I
10.1128/IAI.00641-12
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
People in regions of Schistosoma mansoni endemicity slowly acquire immunity, but why this takes years to develop is still not clear. It has been associated with increases in parasite-specific IgE, induced, some investigators propose, to antigens exposed during the death of adult worms. These antigens include members of the tegumental-allergen-like protein family (TAL1 to TAL13). Previously, in a group of S. mansoni-infected Ugandan males, we showed that IgE responses to three TALs expressed in worms (TAL1, -3, and -5) became more prevalent with age. Now, in a subcohort we examined associations of these responses with resistance to reinfection and use the data to propose a mechanism for the slow development of immunity. IgE was measured 9 weeks posttreatment and at reinfection at 2 years (n = 144). An anti-TAL5 IgE (herein referred to as TAL5 IgE) response was associated with reduced reinfection even after adjusting for age using regression analysis (geometric mean odds ratio, 0.24; P = 0.016). TAL5 IgE responders were a subset of TAL3 IgE responders, themselves a subset of TAL1 responders. TAL3 IgE and TAL5 IgE were highly cross-reactive, with TAL3 the immunizing antigen and TAL5 the cross-reactive antigen. Transcriptional and translational studies show that TAL3 is most abundant in adult worms and that TAL5 is most abundant in infectious larvae. We propose that in chronic schistosomiasis, older individuals have repeatedly experienced IgE antigens exposed when adult worms die (e.g., TAL3) and that this leads to increasing cross-reactivity with antigens of invading larvae (e.g., TAL5). Progressive accumulation of worm/larvae cross-reactivity could explain the age-dependent immunity observed in areas of endemicity.
引用
收藏
页码:4264 / 4270
页数:7
相关论文
共 50 条
  • [41] DIMINISHING CROSS-REACTIVITY IN SCHISTOSOMIASIS SEROLOGY BY APPLYING A SINGLE GLYCAN TARGET APPROACH
    Kildemoes, Anna O.
    Veldhuizen, Tom
    Tanaka, Mio
    van Lieshout, Lisette
    Camprubi-Ferrer, Daniel
    Munoz, Jose
    Clerinx, Jan
    Visser, Leo
    Hamano, Shinjiro
    Njenga, Sammy M.
    Roestenberg, Meta
    van Diepen, Angela
    Hokke, Cornelis H.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (05): : 412 - 412
  • [42] Seroprevalence and Cross-reactivity of Human Polyomavirus 9
    Nicol, Jerome T. J.
    Touze, Antoine
    Robinot, Remy
    Arnold, Francoise
    Mazzoni, Elisa
    Tognon, Mauro
    Coursaget, Pierre
    [J]. EMERGING INFECTIOUS DISEASES, 2012, 18 (08) : 1329 - 1332
  • [43] Molecular basis of IgE cross-reactivity between human β-casein and bovine β-casein, a major allergen of milk
    Bernard, H
    Negroni, L
    Chatel, JM
    Clement, G
    Adel-Patient, K
    Peltre, G
    Creminon, C
    Wal, JM
    [J]. MOLECULAR IMMUNOLOGY, 2000, 37 (3-4) : 161 - 167
  • [44] CROSS-REACTIVITY OF RAT, MOUSE, AND HUMAN IGD
    GOLDING, H
    CUCHENS, MA
    LESLIE, GA
    RITTENBERG, MB
    [J]. JOURNAL OF IMMUNOLOGY, 1979, 123 (06): : 2751 - 2755
  • [45] Serological cross-reactivity between human polyomaviruses
    Moens, Ugo
    Van Ghelue, Marijke
    Song, Xiaobo
    Ehlers, Bernhard
    [J]. REVIEWS IN MEDICAL VIROLOGY, 2013, 23 (04) : 250 - 264
  • [46] CROSS-REACTIVITY IN THE HUMAN IMMUNE-RESPONSE
    PUTTERMAN, C
    DIAMOND, B
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 734 - 734
  • [47] IMMUNOLOGICAL CROSS-REACTIVITY OF HUMAN LIPOPROTEIN(A) WITH PLASMINOGEN
    FLESS, GM
    SCANU, AM
    [J]. ARTERIOSCLEROSIS, 1987, 7 (05): : A505 - A505
  • [48] SUBCLASS DISTRIBUTION AND IGE RESPONSES AFTER TREATMENT IN HUMAN SCHISTOSOMIASIS
    EVENGARD, B
    HAMMARSTROM, L
    SMITH, CIE
    JOHANSSON, SGO
    LINDER, E
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1988, 73 (03): : 383 - 388
  • [49] Molecular characterization and IgE cross-reactivity analysis of juniperus ashei pollen extract
    Alvarez, J.
    Lopez-Matas, M. A.
    Calzada, D.
    Aranda, T.
    Alvarez, F.
    Beitia, J. M.
    Carnes, J.
    [J]. ALLERGY, 2021, 76 : 28 - 29
  • [50] Cross-reactivity and Tolerability of Ertapenem in Patients With IgE-Mediated Hypersensitivity to β-Lactams
    Buonomo, A.
    Pascolini, L.
    Rizzi, A.
    Aruanno, A.
    Pecora, V
    Ricci, A. G.
    Mezzacappa, S.
    Di Rienzo, A.
    Centrone, M.
    Nucera, E.
    Schiavino, D.
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2016, 26 (02) : 100 - 105